The preoperative recurrence score: Predicting early recurrence in peri-hilar cholangiocarcinoma
- Simone Conci 1, Giovanni Catalano 1, Wojciech Polak 2, Francesco Ardito 3, Mario De Bellis 1, Edoardo Poletto 4, Caterina Mele 3, Laura Alaimo 1, Felice Giuliante 3, Bas Groot Koerkamp 2, Andrea Ruzzenente 1
- 1Division of General and Hepatobiliary Surgery, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, University Hospital G.B. Rossi, Verona, Italy.
- 2Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
- 3Hepatobiliary Surgery Unit, Foundation "Policlinico Universitario A. Gemelli", IRCCS, Catholic University, Rome, Italy.
- 4Division of General and Hepatobiliary Surgery, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, University Hospital G.B. Rossi, Verona, Italy; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
- 0Division of General and Hepatobiliary Surgery, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, University Hospital G.B. Rossi, Verona, Italy.
|
October 9, 2024
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A new Preoperative Recurrence Score (PRS) helps predict early recurrence in perihilar cholangiocarcinoma (PCC) patients. This radiological model aids in determining surgical suitability and preventing futile resections.
Area Of Science
- Hepatobiliary Surgery
- Surgical Oncology
- Radiology
Background
- Perihilar cholangiocarcinoma (PCC) recurrence rates after surgery remain high.
- Predictive models for early recurrence are needed to optimize treatment strategies.
Purpose Of The Study
- To develop and validate the Preoperative Recurrence Score (PRS) model.
- To estimate the risk of early recurrence based on preoperative radiological characteristics in PCC patients.
Main Methods
- Retrospective collection of data from PCC patients who underwent surgery.
- Review of preoperative imaging to identify key tumor characteristics.
- Internal development and external validation of the PRS model on independent cohorts.
Main Results
- Tumor size ≥18 mm, portal vein involvement, hepatic artery involvement, and suspicious lymph nodes were significant predictors of recurrence-free survival.
- The PRS demonstrated excellent discrimination in internal (AUC 0.83) and external validation cohorts (AUC 0.84, 0.70).
- High PRS was strongly associated with worse recurrence-free survival, with 1-year recurrence probabilities up to 100% in validation cohorts.
Conclusions
- The Preoperative Recurrence Score (PRS) is a reliable tool for assessing early recurrence risk in PCC.
- PRS can guide decisions regarding upfront surgery, potentially avoiding futile resections in high-risk patients.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

